UPDATE: Oppenheimer Reinstates Alexion Pharmaceuticals (ALXN) at Outperform
Tweet Send to a Friend
(Updated - May 5, 2021 4:57 AM EDT)
Oppenheimer analyst Hartaj Singh reinstates coverage on Alexion Pharmaceuticals (NASDAQ: ALXN) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Hartaj Singh reinstates coverage on Alexion Pharmaceuticals (NASDAQ: ALXN) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
